IFNG and melanoma: We observed that the proportion of the CD8+ T cells producing IFN-γ against B16 melanoma cells was significantly greater in CD8+ T cells from mice immunized with DC/Ad-P19 or DC/Ad-P23, compared to mice immunized with Ad-GFP/DC or Ad-DAP12/DC (Figure 4b).